Optimal sample size allocation for two-arm superiority and non-inferiority trials with binary endpoints

被引:0
|
作者
Kirchner, Marietta [1 ]
Schuepke, Stefanie [2 ,3 ,4 ]
Kieser, Meinhard [1 ,5 ]
机构
[1] Heidelberg Univ, Inst Med Biometry, Heidelberg, Germany
[2] Privatpraxis Kardiol, Frankfurt, Germany
[3] Deutsch Herzzentrum Munich, ISARes Ctr, Munich, Germany
[4] DZHK German Ctr Cardiovasc Res, Partner Site Munich Heart Alliance, Berlin, Germany
[5] Heidelberg Univ, Inst Med Biometry, Im Neuenheimer Feld 130 3, D-69120 Heidelberg, Germany
关键词
allocation ratio; clinical trial; power; sample size; UNEQUAL RANDOMIZATION; CLINICAL-TRIALS;
D O I
10.1002/pst.2375
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The sample size of a clinical trial has to be large enough to ensure sufficient power for achieving the aim the study. On the other side, for ethical and economical reasons it should not be larger than necessary. The sample size allocation is one of the parameters that influences the required total sample size. For two-arm superiority and non-inferiority trials with binary endpoints, we performed extensive computations over a wide range of scenarios to determine the optimal allocation ratio that minimizes the total sample size if all other parameters are fixed. The results demonstrate, that for both superiority and non-inferiority trials the optimal allocation may deviate considerably from the case of equal sample size in both groups. However, the saving in sample size when allocating the total sample size optimally as compared to balanced allocation is typically small.
引用
收藏
页码:678 / 686
页数:9
相关论文
共 50 条
  • [21] Re-Formulating Non-inferiority Trials as Superiority Trials: The Case of Binary Outcomes
    Durkalski, Valerie L.
    Berger, Vance W.
    BIOMETRICAL JOURNAL, 2009, 51 (01) : 185 - 192
  • [22] ¿Clinical trials of superiority, non-inferiority or equivalence?
    Manterola, Carlos
    Hernandez-Leal, Maria Jose
    Otzen, Tamara
    Holguin, Juan Pablo
    Salgado, Carla
    Grande, Luis
    REVISTA CHILENA DE INFECTOLOGIA, 2024, 41 (01): : 157 - 164
  • [23] Pivotal trials of orthopedic surgical devices in the United States: predominance of two-arm non-inferiority designs
    S. Raymond Golish
    Trials, 18
  • [24] Pivotal trials of orthopedic surgical devices in the United States: predominance of two-arm non-inferiority designs
    Golish, S. Raymond
    TRIALS, 2017, 18
  • [25] Hybrid classical-Bayesian approach to sample size determination for two-arm superiority clinical trials
    Sambucini, Valeria
    INTERNATIONAL JOURNAL OF BIOSTATISTICS, 2024,
  • [26] Blinded sample size reassessment in non-inferiority and equivalence trials
    Friede, T
    Kieser, M
    STATISTICS IN MEDICINE, 2003, 22 (06) : 995 - 1007
  • [27] Bayesian sample size calculations for a non-inferiority test of two proportions in clinical trials
    Daimon, Takashi
    CONTEMPORARY CLINICAL TRIALS, 2008, 29 (04) : 507 - 516
  • [28] Non-Inferiority Test in a Two-Arm Trial and a Three-Arm Trial Including a Placebo
    Lee, Ji Sun
    Kim, Dongjae
    KOREAN JOURNAL OF APPLIED STATISTICS, 2008, 21 (06) : 947 - 957
  • [29] Non-inferiority tests for binary endpoints with variable margins
    Ren, Yixin
    Wang, Chao
    Shen, Meiyu
    Tsong, Yi
    JOURNAL OF BIOPHARMACEUTICAL STATISTICS, 2019, 29 (05) : 822 - 833
  • [30] Evaluating "superiority", "'equivalence" and "non-inferiority" in clinical trials
    Turan, Fatma Nesrin
    Senocak, Mustafa
    ANNALS OF SAUDI MEDICINE, 2007, 27 (04) : 284 - 288